Post

The FDA just approved daraxonrasib, a breakthrough drug for advanced pancreatic cancer that doubles survival time. This is huge: pancreatic cancer was once thought untreatable. The researchers received a standing ovation when they presented the trial results, unheard of at scientific conferences.